Changes in health related quality of life in patients with Parkinson's disease with and without posteroventral pallidotomy

Acta Neurochirurgica

Volumn 142, Issue 7, 2000, Pages 759-768

  D'Antonio, L L ^a   Zimmerman, G J ^a   Iacono, R P ^a  

^a LOMA LINDA UNIVERSITY   (United States)

Author keywords

Outcome measures; Parkinson's disease; Posteroventral pallidotomy; Quality of life

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PALLIDOTOMY; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GLOBUS PALLIDUS; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; OUTCOME ASSESSMENT (HEALTH CARE); PARKINSON DISEASE; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 0033924058     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007010070090     Document Type: Article

References (33)

1. 1. Aaronson NK (1988) Quality of life: what is it? How should it be measured. Oncology 2: 69-76
2. 2. Cella DF (1994) Quality of life: Concepts and Definition. J Pain Symptom Manage 9: 186-192
3. 3. Cella DF (1997) The manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Scales. Center on Outcomes, Research and Education (CORE). Evanston, IL, Evanston Northwestern Healthcare and Northwestern University, Version 4
4. 4. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J, Eckberg K, Lloyd S, Purl S, Blendowski C, Goodman M, Barnicle M, Stewart I, McHale M, Bonomi P, Kaplan E, Taylor S, Thomas CR, Harris J (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11: 570-579
5. 5. Cotzias GC, Van Woert MH, Schiffer LM (1967) Aromatic amino acids and modification of parkinsonism. N Engl J Med 276: 374-379
6. 6. Fahn S (1974) "On-off" phenomenon with levodopa therapy in parkinsonism. Neurology 24: 431-441
7. 7. Fahn S, Elton RL (1987) Members of the UPDRS Development Committee: Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson's disease, 2nd edn. Macmillan Health Care Information, Florham Park, NJ. pp 153-164
8. 8. Fairclough DL and Cella DF (1996) Functional Assessment of Cancer Therapy (FACT-G): Non-response to individual questions. Qual Life Res 5: 321-329
9. 9. Fazzini E, Dogali M, Sterio D, Eidelberg D, Beric A (1997) Stereotactic pallidotomy for Parkinson's disease: A long-term follow-up of unilateral pallidotomy. Neurology 48: 1273-1277
10. 10. Godwin-Austen RB (1973) The long-term therapeutic effects of levodopa in the treatment of parkinsonism. Adv Neurol 3: 23-27
11. 11. Goetz CG, Diederich NJ (1996) There is a renaissance of interest in pallidotomy for Parkinson's disease. Nat Med 2: 510-514
12. 12. Gotay CC, Korn EL, McCabe MS, Moore TD, Cheson BD (1992) Quality-of-life assessment in cancer treatment protocols: Research issues in protocol development. J Natl Cancer Inst 84: 575-579
13. 13. Gotay CC and Moore TD (1992) Assessing quality of life in head and neck cancer. Qual Life Res 1: 5-17
14. 14. Guyatt GH, Feeny DH, Patrick DL (1993) Measuring health-related quality of life. Ann Int Med 118: 622-629
15. 15. Hoehn MM, Yahr MD. Parkinsonism (1967) onset, progression, and mortality. Neurology 17: 427-442
16. 16. Iacono RP, Carlson JD, Kuniyoshi SM, Li YJ, Mohamed AS, Maeda G (1997) Electrophysiologic target localization in posteroventral pallidotomy. Acta Neurochir (Wien) 139: 433-441
17. 17. Iacono RP, Henderson JM, Lonser RR (1995) Combined stereotactic thalamotomy and posteroventral pallidotomy for Parkinson's disease. J Image Guid Surg 1: 133-140
18. 18. Iacono RP, Lonser RR, Yamada S (1994) Contemporaneous bilateral posteroventral pallidotomy for early onset "juvenile type" Parkinson's disease. Acta Neurochir (Wien) 131: 247-252
19. 19. Iacono RP, Shima F, Lonser RR, Kuniyoshi S, Maeda G, Yamada S (1995) The results, indications, and physiology of posteroventral pallidotomy for patients with Parkinson's disease. Neurosurgery 36: 1118-1127
20. 20. Jenkinson C, Peto V, Fitzpatrick R, Greenhall R, Hyman N (1995) Self-reported functioning and well-being in patients with Parkinson's disease: Comparison of the Short-form Health Survey (SF-36) and the Parkinson's disease questionnaire (PDQ-39). Age Ageing 24: 505-509
21. 21. Kelly PJ (1995) Pallidotomy in Parkinson's disease [editorial; comment]. Neurosurgery 36: 1154-1157
22. 22. Laitinen LV, Bergenheim AT, Hariz MI (1992) Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 76: 53-61
23. 23. Lang AE, Lozano AM, Montgomery E, Duff J, Tasker R, Hutchinson W (1997) Posteroventral medial pallidotomy in advanced Parkinson's disease. N Engl J Med 337: 1036-1042
24. 24. Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T, Watts R (1992) Core assessment program for intra-cerebral transplantations (CAPIT). Mov Disord 7: 2-13
25. 25. Lozano AM, Lang AE, Galvez-Jimenez N, Miyasaki J, Duff J, Hutchinson WD, Dostrovsky JO (1995) Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet 346: 1383-1387
26. 26. Marsden CD (1990) Parkinson's disease. (Review article). Lancet 335: 948-952
27. 27. Martinez-Martin P (1993) Rating scales in Parkinson's disease. In: Jankovic J and Tolosa E (eds) Parkinson's disease and movement disorders, 2nd eds. Williams and Wilkins, Baltimore, pp 281-292
28. 28. Melamed E, Hefti F, Wurtman RJ (1980) Nonaminergic striatal neurons convert exogenous L-dopa to dopamine in parkinsonism. Ann Neurol 8: 559-563
29. 29. Nutt JG (1995) Management of parkinsonism and treatment of associated complications. Curr Opin Neurol 8: 327-330
30. 30. Peterman A, D'Antonio L, Zimmerman G (1997) Measuring global quality of life in patients with Parkinson's disease. Mov Disord 12: 136 (abstr)
31. 31. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R (1995) The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 4: 241-248
32. 32. Poewe W (1993) L-dopa in Parkinson's disease, mechanisms of action and pathophysiology of late failure. In: Jankovic J, Tolosa E (eds) Parkinson's disease and movement disorders, 2nd edn. Williams and Wilkins, Baltimore, pp 103-113
33. 33. Testa MA and Simonson DC (1996) Assessment of Quality-of-life outcomes. N Engl J Med 334: 835-840